Abstract:Objective To explore the possibility and safety of ~(32)P-colloidal chromic phosphate interstitial injection.Methods Ten Beagle dogs were randomly divided into 5 groups (n ＝ 2) according to different doses (185 and 370 MBq) ,different sites (gluteus maximus and liver) and cold colloid as a control group.At different time-points after surgery,the weights of dogs were measured,and the blood and blood biochemical inspections were examined.ECT imaging was performed and histomorphology was observed dynamically.The radioactive counts of body surface for 90 days,blood for 12 weeks and urine and feces for 30 days were measured continuously.Measured data were expressed by mean ±standard error ((x) ±s) and SPSS 13.0 software was used for statistical analysis.Results ECT imaging demonstrated that the whole liver imaging was obtained although the radioactive distribution was uneven in liver groups,and the radioactivity concentrated continuously in the area of injection,but no liver imaging in muscle groups.Dogs in group 4 lost weight progressively and reduced by 2.7 kg till 45 d after operation.While the mean weight increments in the other groups were 3.0,1.6,0.8 and 3.1 kg in order.In group 4,PLT and RBC reduced obviously.Dogs died at 23 or 45 d.AST and ALT were elevated sharply before death.In the other groups,blood and blood biochemistry inspection showed there were no significant statistical differences.The highest radioactive counts after operation were obtained from the injection spot,while the urinary bladder and the spleen were followed.The peak of blood cpm in liver groups presented at 5 min.Peak values were 0.5 × 10~7/min and 1.0 × 10~7/min,respectively.The blood cpm in the muscle groups was always maintained at 3 × l0~5/min.Histology study showed the hyperemia dropsy changes in muscle groups and 185 MBq liver group in 4 weeks,while after 8 weeks the organizational structure restored normally.There were partial liver cells necrosis in 4 weeks,and the massive liver cells balloon type changes in 6 weeks,as well as obvious hyperemia dropsy and the hepatic lobe structure unclear in 370 MBq liver group.For the radioactive counts of urine and excrement,the peak appeared at 13 and 12 d respectively,and the peak values were (42.0 ±3.3) × 10~4 and (29.6 ±4.5) ×10~4 /min in muscle groups,respectively ;while the peak appeared at 5 and 9 d,respectively and the peak values were (49.0 ± 10.2) × 10~4 and (28.5 ± 7.1) × 10~4 /min in liver groups,respectively.Cumulative excretion ratios in urine and excrement were 36.58% and 10.62% in muscle groups,respectively and 23.48% and 8.76% in liver groups till 30 d,respectively.The liver absorbed doses were 30.6 and 55.6 Gy in liver groups,while those were 2.3 and 6.5 Gy in muscle groups.The maximus absorbed doses of gluteus were 53.4 and 98.1 Gy in muscle groups.Conclusions When ~(32)P- colloidal chromic phosphate of 794.39 MBq/m~2 was injected into the liver of Beagle,the liver absorbed dose was 56 Gy,which could be lethal dose for its strong liver toxicity and systemic side effects.Injection of 463.98-772.93 MBq/m~2 in muscle of Beagle could be safe.~(32) P-colloidal chromic phosphate interstitial injection is secure to treat the solid tumors with poor and middle blood supply which could be reached by puncture.

Toxicity of glufosfamide in Beagle dogs following intravenous injection

Systemic Toxicity and Toxicokinetics of a High Dose of Polyethylene Glycol 400 in Dogs Following Intravenous Injection

Thirteen-week Veinal Toxicity Study of Ginkgolides Sodium Chloride Injection in Beagle Dogs

Research on the Long-Term Toxicological Effects of Suxiaokangyun Capsules in Beagle Dogs

Toxicity and Toxicokinetics of a Four-Week Repeated Gavage of Levamisole in Male Beagle Dogs: A Good Laboratory Practice Study

13 Weeks Intravenous Repeated Dose Toxicity Study of Dexrabeprazole Sodium for Injection in Beagle Dogs

Cumulative Damage Effect of ~(32) P-colloidal Chromic Phosphate Interstitial Delivery on Beagles

Pharmacokinetic Study of Single and Multiple Oral Administration of Glutamine in Healthy Beagles.

Acute Toxicity of Intravenous Isoflurane in Beagles

Pharmacokinetics of Glutathione and the Component Amino Acids by Gavage and iv in Beagle Dogs

The 14-Day Repeated-Dose Toxicity Study of a Fixed-Dose Combination, QXOH/levobupivacaine, Via Subcutaneous Injection in Beagle Dogs

Investigation of Toxicological Effects of Shuanghuanglian Injection in Beagle Dogs by Metabonomic and Traditional Approaches

Toxicity Study of 28-Day Subcutaneous Injection of Arctigenin in Beagle Dogs

Toxicokinetics of CXY-001 Following Single and Repeated Administration to Beagle Dogs

Toxicity study of long-term intravenous administration of emulsified isoflurane in beagle dogs

Toxicity of a Novel Anti-Tumor Agent 20(S)-Ginsenoside Rg3: A 26-Week Intramuscular Repeated Administration Study in Beagle Dogs

Genotoxicity and subchronic toxicological study of a novel ginsenoside derivative 25-OCH 3 -PPD in beagle dogs

Safety evaluation of 32P-chromic phosphate-poly L lactic acid particles interstitially implanted into livers of Beagle dogs.

Subchronic toxicity and plasma pharmacokinetic studies on wogonin, a natural flavonoid, in Beagle dogs.

Preclinical safety evaluation of ET-26 hydrochloride, a novel intravenous anesthetic agent, in beagle dogs.

Trace quantification of GL-V9 and its glucuronide metabolites (5-O-glucuronide GL-V9) in Beagle dog plasma by UPLC–MS/MS and its application to a pharmacokinetic study